Wu L - Search Results

1

Enhanced nuclear delivery of anti-cancer drugs using micelles containing releasable membrane fusion peptide and nuclear-targeting retinoic acid.

Zhou Z , Liu Y , Wu L , Li L , Huang Y . Zhou Z , et al. Among authors: wu l. J Mater Chem B. 2017 Sep 14;5(34):7175-7185. doi: 10.1039/c7tb01177f. Epub 2017 Aug 21. J Mater Chem B. 2017. PMID: 32263908

2

Iron-mimic peptide converts transferrin from foe to friend for orally targeting insulin delivery.

Liu M , Wu L , Shan W , Cui Y , Huang Y . Liu M , et al. Among authors: wu l. J Mater Chem B. 2018 Jan 28;6(4):593-601. doi: 10.1039/c7tb02450a. Epub 2018 Jan 8. J Mater Chem B. 2018. PMID: 32254488

3

A strategy for developing effective orally-delivered nanoparticles through modulation of the surface "hydrophilicity/hydrophobicity balance".

Cui Y , Shan W , Liu M , Wu L , Huang Y . Cui Y , et al. Among authors: wu l. J Mater Chem B. 2017 Feb 14;5(6):1302-1314. doi: 10.1039/c6tb02475k. Epub 2017 Jan 27. J Mater Chem B. 2017. PMID: 32263598

4

Core-shell stability of nanoparticles plays an important role for overcoming the intestinal mucus and epithelium barrier.

Liu M , Wu L , Zhu X , Shan W , Li L , Cui Y , Huang Y . Liu M , et al. Among authors: wu l. J Mater Chem B. 2016 Sep 21;4(35):5831-5841. doi: 10.1039/c6tb01199c. Epub 2016 Aug 15. J Mater Chem B. 2016. PMID: 32263756

5

Enhanced Oral Delivery of Protein Drugs Using Zwitterion-Functionalized Nanoparticles to Overcome both the Diffusion and Absorption Barriers.

Shan W, Zhu X, Tao W, Cui Y, Liu M, Wu L, Li L, Zheng Y, Huang Y. Shan W, et al. Among authors: wu l. ACS Appl Mater Interfaces. 2016 Sep 28;8(38):25444-53. doi: 10.1021/acsami.6b08183. Epub 2016 Sep 13. ACS Appl Mater Interfaces. 2016. PMID: 27588330

6

A pH-responsive sequential-disassembly nanohybrid for mitochondrial targeting.

Li L, Sun W, Li L, Liu Y, Wu L, Wang F, Zhou Z, Zhang Z, Huang Y. Li L, et al. Among authors: wu l. Nanoscale. 2017 Jan 7;9(1):314-325. doi: 10.1039/c6nr07004c. Epub 2016 Dec 2. Nanoscale. 2017. PMID: 27910990

7

Subcellular co-delivery of two different site-oriented payloads for tumor therapy.

Yang Q, Wu L, Li L, Zhou Z, Huang Y. Yang Q, et al. Among authors: wu l. Nanoscale. 2017 Jan 26;9(4):1547-1558. doi: 10.1039/c6nr08200a. Nanoscale. 2017. PMID: 28067924

8

Novel Solid Lipid Nanoparticle with Endosomal Escape Function for Oral Delivery of Insulin.

Xu Y, Zheng Y, Wu L, Zhu X, Zhang Z, Huang Y. Xu Y, et al. Among authors: wu l. ACS Appl Mater Interfaces. 2018 Mar 21;10(11):9315-9324. doi: 10.1021/acsami.8b00507. Epub 2018 Mar 8. ACS Appl Mater Interfaces. 2018. PMID: 29484890

9

Nanoparticles with surface features of dendritic oligopeptides as potential oral drug delivery systems.

Bai Y, Zhou R, Wu L, Zheng Y, Liu X, Wu R, Li X, Huang Y. Bai Y, et al. Among authors: wu r, wu l. J Mater Chem B. 2020 Apr 1;8(13):2636-2649. doi: 10.1039/c9tb02860a. J Mater Chem B. 2020. PMID: 32129375

10

Lipid nanovehicles with adjustable surface properties for overcoming multiple barriers simultaneously in oral administration.

Wu L, Liu M, Shan W, Cui Y, Zhang Z, Huang Y. Wu L, et al. Int J Pharm. 2017 Mar 30;520(1-2):216-227. doi: 10.1016/j.ijpharm.2017.02.015. Epub 2017 Feb 6. Int J Pharm. 2017. PMID: 28185960

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33,330 results

Search Page

Filters